nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of approximations to recover incompletely reported logistic regression models depended on other available information
|
Takada, Toshihiko |
|
|
143 |
C |
p. 81-90 |
artikel |
2 |
Analyses of repeatedly measured continuous outcomes in randomized controlled trials needed substantial improvements
|
Ren, Yan |
|
|
143 |
C |
p. 105-117 |
artikel |
3 |
A pilot living clinical practice guidelines approach was feasible and acceptable to guideline panel members
|
Bragge, Peter |
|
|
143 |
C |
p. 22-29 |
artikel |
4 |
Awareness, value and use of the Australian living guidelines for the clinical care of people with COVID-19: an impact evaluation
|
Millard, Tanya |
|
|
143 |
C |
p. 11-21 |
artikel |
5 |
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents
|
Boesen, Kim |
|
|
143 |
C |
p. 242-253 |
artikel |
6 |
Editorial Board
|
|
|
|
143 |
C |
p. IFC |
artikel |
7 |
Editors’ Choice March 2022: Harmonisation needed in a) assessing harms and b) guideline classification of certainty of evidence and strength
|
Tugwell, Peter |
|
|
143 |
C |
p. A4-A5 |
artikel |
8 |
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies
|
Foroutan, Farid |
|
|
143 |
C |
p. 202-211 |
artikel |
9 |
Harms in Systematic Reviews Paper 1: An introduction to research on harms
|
Qureshi, Riaz |
|
|
143 |
C |
p. 186-196 |
artikel |
10 |
Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms
|
Qureshi, Riaz |
|
|
143 |
C |
p. 224-241 |
artikel |
11 |
Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin
|
Qureshi, Riaz |
|
|
143 |
C |
p. 212-223 |
artikel |
12 |
Increased interaction and procedural flexibility favoured participation: Study across European cohorts of preterm born individuals
|
Marques, Sandra CS. |
|
|
143 |
C |
p. 169-177 |
artikel |
13 |
Interrupted time-series analysis showed unintended consequences of non-pharmaceutical interventions on pediatric hospital admissions
|
Moore, Hannah C |
|
|
143 |
C |
p. 1-10 |
artikel |
14 |
Key concepts in clinical epidemiology: addressing and reporting sources of bias in randomized controlled trials
|
Kotz, Daniel |
|
|
143 |
C |
p. 197-201 |
artikel |
15 |
Large-scale infectious disease testing programs have little consideration for equity: findings from a scoping review
|
Ost, Katarina |
|
|
143 |
C |
p. 30-60 |
artikel |
16 |
Many trials of hydroxychloroquine for SARS-CoV-2 were redundant and potentially unethical: an analysis of the NIH clinical trials registry
|
Yogendrakumar, Vignan |
|
|
143 |
C |
p. 73-80 |
artikel |
17 |
Methodology over metrics: Response to Van Calster et al
|
Bunce, Catey |
|
|
143 |
C |
p. 254 |
artikel |
18 |
Minimal important changes and differences were estimated for Oxford hip and knee scores following primary and revision arthroplasty
|
Sabah, Shiraz A. |
|
|
143 |
C |
p. 159-168 |
artikel |
19 |
New methods facilitated the process of prioritizing questions and health outcomes in guideline development
|
Wiercioch, Wojtek |
|
|
143 |
C |
p. 91-104 |
artikel |
20 |
Pneumococcal vaccination prevented severe LRTIs in adults: a causal inference framework applied in registry data
|
Mamouris, Pavlos |
|
|
143 |
C |
p. 118-127 |
artikel |
21 |
Present state bias in transition ratings was accurately estimated in simulated and real data
|
Terluin, Berend |
|
|
143 |
C |
p. 128-136 |
artikel |
22 |
Quality assessment practice in systematic reviews of mediation studies: results from an overview of systematic reviews
|
Vo, Tat-Thang |
|
|
143 |
C |
p. 137-148 |
artikel |
23 |
Review of pragmatic trials found that multiple primary outcomes are common but so too are discrepancies between protocols and final reports
|
Nevins, Pascale |
|
|
143 |
C |
p. 149-158 |
artikel |
24 |
Table of Contents
|
|
|
|
143 |
C |
p. A2-A3 |
artikel |
25 |
The patient engagement evaluation tool was valid for clinical practice guideline development
|
Moore, Ainsley |
|
|
143 |
C |
p. 61-72 |
artikel |
26 |
Visual transformation for guidelines presentation of the strength of recommendations and the certainty of evidence
|
Klugar, Miloslav |
|
|
143 |
C |
p. 178-185 |
artikel |